JP2015512403A5 - - Google Patents

Download PDF

Info

Publication number
JP2015512403A5
JP2015512403A5 JP2015503344A JP2015503344A JP2015512403A5 JP 2015512403 A5 JP2015512403 A5 JP 2015512403A5 JP 2015503344 A JP2015503344 A JP 2015503344A JP 2015503344 A JP2015503344 A JP 2015503344A JP 2015512403 A5 JP2015512403 A5 JP 2015512403A5
Authority
JP
Japan
Prior art keywords
composition
composition according
treatment
synthetic cationic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015503344A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015512403A (ja
JP6224069B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/032535 external-priority patent/WO2013142374A1/en
Publication of JP2015512403A publication Critical patent/JP2015512403A/ja
Publication of JP2015512403A5 publication Critical patent/JP2015512403A5/ja
Application granted granted Critical
Publication of JP6224069B2 publication Critical patent/JP6224069B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015503344A 2012-03-23 2013-03-15 組織適合特性を有する抗菌剤の組成物および使用 Active JP6224069B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201261615150P 2012-03-23 2012-03-23
US61/615,150 2012-03-23
US201261625760P 2012-04-18 2012-04-18
US201261625757P 2012-04-18 2012-04-18
US61/625,757 2012-04-18
US61/625,760 2012-04-18
US201261716242P 2012-10-19 2012-10-19
US61/716,242 2012-10-19
PCT/US2013/032535 WO2013142374A1 (en) 2012-03-23 2013-03-15 Compositions and uses of antimicrobial materials with tissue-compatible properties

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017194019A Division JP2018020175A (ja) 2012-03-23 2017-10-04 組織適合特性を有する抗菌剤の組成物および使用

Publications (3)

Publication Number Publication Date
JP2015512403A JP2015512403A (ja) 2015-04-27
JP2015512403A5 true JP2015512403A5 (enExample) 2016-02-04
JP6224069B2 JP6224069B2 (ja) 2017-11-01

Family

ID=49223273

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2015503344A Active JP6224069B2 (ja) 2012-03-23 2013-03-15 組織適合特性を有する抗菌剤の組成物および使用
JP2017194019A Pending JP2018020175A (ja) 2012-03-23 2017-10-04 組織適合特性を有する抗菌剤の組成物および使用
JP2019166236A Active JP7255787B2 (ja) 2012-03-23 2019-09-12 組織適合特性を有する抗菌剤の組成物および使用
JP2020184556A Pending JP2021020964A (ja) 2012-03-23 2020-11-04 組織適合特性を有する抗菌剤の組成物および使用
JP2022176900A Pending JP2023011850A (ja) 2012-03-23 2022-11-04 組織適合特性を有する抗菌剤の組成物および使用
JP2025019121A Pending JP2025065375A (ja) 2012-03-23 2025-02-07 組織適合特性を有する抗菌剤の組成物および使用

Family Applications After (5)

Application Number Title Priority Date Filing Date
JP2017194019A Pending JP2018020175A (ja) 2012-03-23 2017-10-04 組織適合特性を有する抗菌剤の組成物および使用
JP2019166236A Active JP7255787B2 (ja) 2012-03-23 2019-09-12 組織適合特性を有する抗菌剤の組成物および使用
JP2020184556A Pending JP2021020964A (ja) 2012-03-23 2020-11-04 組織適合特性を有する抗菌剤の組成物および使用
JP2022176900A Pending JP2023011850A (ja) 2012-03-23 2022-11-04 組織適合特性を有する抗菌剤の組成物および使用
JP2025019121A Pending JP2025065375A (ja) 2012-03-23 2025-02-07 組織適合特性を有する抗菌剤の組成物および使用

Country Status (16)

Country Link
US (4) US9446090B2 (enExample)
EP (2) EP2827841B8 (enExample)
JP (6) JP6224069B2 (enExample)
KR (2) KR102141254B1 (enExample)
CN (1) CN104582688A (enExample)
AU (2) AU2013235336B2 (enExample)
BR (1) BR112014023068B1 (enExample)
CA (1) CA2867903C (enExample)
ES (1) ES2991989T3 (enExample)
HU (1) HUE069626T2 (enExample)
IN (1) IN2014DN08299A (enExample)
MX (2) MX344635B (enExample)
PL (1) PL2827841T3 (enExample)
RU (1) RU2680959C2 (enExample)
WO (1) WO2013142374A1 (enExample)
ZA (1) ZA201407121B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101801521B (zh) 2007-05-14 2015-06-17 纽约州立大学研究基金会 生物膜中细菌细胞内的生理学分散响应诱导
JP6224069B2 (ja) * 2012-03-23 2017-11-01 アミクローブ，インコーポレイテッド 組織適合特性を有する抗菌剤の組成物および使用
US10046137B2 (en) 2014-02-21 2018-08-14 Avadim Technologies, Inc. Method for maintenance of urethral catheters
WO2016006693A1 (ja) * 2014-07-11 2016-01-14 株式会社メニコン 視認性確保材および視認性確保材吐出装置
DK3185882T3 (da) * 2014-08-29 2020-01-27 Region Midtjylland Positivt ladede copolymerer til anvendelse som antimikrobielle midler
EP3221012A2 (en) * 2014-11-19 2017-09-27 Avadim Technologies, Inc. Method for the prevention and treatment of acne
WO2018187617A1 (en) * 2017-04-06 2018-10-11 Amicrobe, Inc. Compositions and uses of locally applied antimicrobials with enhanced performance and safety
GB201711555D0 (en) * 2017-07-18 2017-08-30 Kent Innovation & Entpr Antibacterial compounds
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
EP3934753B1 (en) 2019-03-04 2025-11-05 Capretto EHF. Microbial removal
CN109847090B (zh) * 2019-03-25 2021-08-31 深圳市康乐美科技有限公司 一种具有抗菌、柔软特性的卫生巾
US12447188B2 (en) 2019-06-12 2025-10-21 Avadim Holdings, Inc. Compositions and methods for the antiseptic treatment of biofilms on mammalian tissue
US20230149333A1 (en) * 2020-04-08 2023-05-18 Amicrobe, Inc. Compositions and uses of locally applied synthetic amino acid polymers for prevention and treatment of viral infections
CN112048084A (zh) * 2020-08-21 2020-12-08 浙江隆泰医疗科技股份有限公司 一种低温交联的聚乙烯醇复合抗菌肽材料的制备方法

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU595040B2 (en) 1986-07-01 1990-03-22 Ici Australia Operations Proprietary Limited Cyclohexane-1, 3-dione herbicides
US5636643A (en) * 1991-11-14 1997-06-10 Wake Forest University Wound treatment employing reduced pressure
US6632922B1 (en) 1998-03-19 2003-10-14 The Regents Of The University Of California Methods and compositions for controlled polypeptide synthesis
US6680365B1 (en) 1998-03-19 2004-01-20 The Regents Of The University Of California Methods and compositions for controlled polypeptide synthesis
US6686446B2 (en) 1998-03-19 2004-02-03 The Regents Of The University Of California Methods and compositions for controlled polypeptide synthesis
TW570805B (en) 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
CA2363141C (en) * 1999-02-26 2010-04-06 Novartis Vaccines And Diagnostics, Inc. Microemulsions with adsorbed macromolecules and microparticles
MXPA03002640A (es) * 2000-09-28 2003-06-19 Chiron Corp Microparticulas para la distribucion de acidos nucleicos heterologos.
US6835536B2 (en) * 2001-08-21 2004-12-28 Micrologix Biotech Inc. Antimicrobial cationic peptides and formulations thereof
US6818732B2 (en) 2001-08-30 2004-11-16 The Regents Of The University Of California Transition metal initiators for controlled poly (beta-peptide) synthesis from beta-lactam monomers
JP2003171463A (ja) 2001-12-06 2003-06-20 Chisso Corp ポリリジン及びその製造法
WO2003067311A1 (fr) 2002-02-07 2003-08-14 Ophtecs Corporation Solution pour lentilles de contact
LT1585548T (lt) * 2002-12-09 2018-09-25 Abraxis Bioscience, Llc Farmakologinių agentų kompozicijos ir įvedimo būdai
US7067482B2 (en) * 2003-07-11 2006-06-27 Theravance, Inc. Cross-linked glycopeptide-cephalosporin antibiotics
US7314857B2 (en) * 2003-08-25 2008-01-01 Kane Biotech Inc. Synergistic antimicrobial compositions and methods of inhibiting biofilm formation
WO2005018701A1 (en) * 2003-08-25 2005-03-03 Kane Biotech Inc. Synergistic antimicrobial compositions and methods of inhibiting biofilm formation
DE602004012894T2 (de) * 2003-12-30 2009-05-14 Bioactive Polymers Ab Oberflächenschutz von frei liegenden biologischen geweben
ATE381945T1 (de) 2004-03-12 2008-01-15 Intercell Ag Verfahren zur solubilisierung von peptid- mischungen
EP1778720B1 (en) 2004-08-18 2010-09-01 Novabiotics Limited Antimicrobial peptides comprising an arginine- and/or lysine-containing motif
BRPI0609801B1 (pt) * 2005-06-06 2018-05-29 Novozymes Adenium Biotech A/S Polipeptídeo, polinucleotídeo, construção de ácido nucleico, vetor de expressão recombinante,microrganismo recombinante, método para produção do polipeptídeo, composição antimibrobiana, método in vitro para matar ou inibir o crescimento 5 de células microbianas, e, uso de um polipeptídeo antimicrobiano
US20080139450A1 (en) * 2005-07-01 2008-06-12 Srinivasa Madhyastha Antimicrobial Compositions and Uses Thereof
US20070190110A1 (en) * 2006-02-10 2007-08-16 Pameijer Cornelis H Agents and devices for providing blood clotting functions to wounds
AU2007329531B2 (en) * 2006-12-01 2013-10-10 The Regents Of The University Of California Vesicles of self-assembling block copolymers and methods for making and using the same
JP2010531189A (ja) 2007-06-25 2010-09-24 リポペプチド・アクチエボラーグ 新しい医療用製品
US20090081249A1 (en) * 2007-08-27 2009-03-26 Massachusetts Institute Of Technology Bi-Functional Polymer-Attached Inhibitors of Influenza Virus
JP5467366B2 (ja) 2008-03-10 2014-04-09 国立大学法人 東京大学 非荷電性親水性ブロック及び側鎖の一部に疎水性基が導入されたカチオン性のポリアミノ酸ブロックを含んでなる共重合体、その使用
CN102065901B (zh) * 2008-06-19 2013-03-06 日本新药株式会社 药物载体
GB0818074D0 (en) 2008-10-02 2008-11-05 Lytix Biopharma As Treatment of biofilms
DK2349310T3 (da) * 2008-10-20 2014-08-11 Moerae Matrix Inc Polypeptid til behandling eller forebyggelse af adhæsioner
US8753692B2 (en) 2009-01-23 2014-06-17 Kane Biotech Inc. Biofilm-removing antimicrobial compositions and uses thereof
GB0905451D0 (en) * 2009-03-31 2009-05-13 Novabiotics Ltd Biofilms
AU2011247584B2 (en) * 2010-04-27 2016-01-14 Lysando Ag Method of reducing biofilms
CA2809093C (en) * 2010-08-23 2015-11-24 The Regents Of The University Of California Compositions and uses of materials with high antimicrobial activity and low toxicity
JP5613779B2 (ja) * 2011-01-19 2014-10-29 株式会社メニコン コンタクトレンズ用液剤
US9781949B2 (en) * 2011-03-31 2017-10-10 The University Of Massachusetts Antimicrobial delivery systems, methods of manufacture, and methods of use thereof
JP6224069B2 (ja) 2012-03-23 2017-11-01 アミクローブ，インコーポレイテッド 組織適合特性を有する抗菌剤の組成物および使用
DE102014101663A1 (de) 2014-02-11 2015-08-13 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Synthetische artifizielle Peptide mit antimikrobieller Wirkung
WO2016044683A1 (en) 2014-09-19 2016-03-24 Tensive Controls, Inc. Anti-microbial peptides
US20160120936A1 (en) 2014-10-30 2016-05-05 Karen Troxel Methods of preventing surgical site infections
JP2016113373A (ja) 2014-12-11 2016-06-23 エスポ化学株式会社 抗菌性、抗ウイルス性を有する水溶性組成物
WO2018187617A1 (en) 2017-04-06 2018-10-11 Amicrobe, Inc. Compositions and uses of locally applied antimicrobials with enhanced performance and safety
JP2021514985A (ja) * 2018-03-02 2021-06-17 ジャニュアリー セラピューティクス，インク． ナノ粒子組成物

Similar Documents

Publication Publication Date Title
JP2015512403A5 (enExample)
Dixon et al. Managing Diabetic Foot Ulcers: Pharmacotherapy for Wound Healing: D. Dixon, M. Edmonds
US12016898B2 (en) Compositions and uses of antimicrobial materials with tissue-compatible properties
Thattaruparambil Raveendran et al. Ciprofloxacin-and fluconazole-containing fibrin-nanoparticle-incorporated chitosan bandages for the treatment of polymicrobial wound infections
Sarheed et al. Antimicrobial dressings for improving wound healing
Bertesteanu et al. Polymicrobial wound infections: pathophysiology and current therapeutic approaches
Rathna et al. Advancements in wound healing: integrating biomolecules, drug delivery carriers, and targeted therapeutics for enhanced tissue repair
KR20120022930A (ko) 은 설파디아진 및 키토산을 사용하여 제조한 약용 크림 및 이의 제조 방법
JP2020513016A5 (enExample)
Karri et al. Understanding the implications of pharmaceutical excipients and additives in the treatment of diabetic foot ulcers
US20240366717A1 (en) Antimicrobial matrix formed from peptide hydrogels
Abzaeva et al. Modern topical hemostatic agents and unique representatives of their new generation
Khan et al. Emerging Trend of Thiolated Polymers/materials and nanomedicine in wound healing
RU2019103612A (ru) Композиции и применение противомикробных материалов со свойствами биологической совместимости
Reddy Karri et al. Understanding the implications of pharmaceutical excipients and additives in the treatment of diabetic foot ulcers.
HK1206614B (en) Compositions and uses of antimicrobial materials with tissue-compatible properties